US 11859010
Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof
granted A61KA61K2039/505A61P
Quick answer
US patent 11859010 (Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof) held by CytomX Therapeutics, Inc. expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CytomX Therapeutics, Inc.
- Grant date
- Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00